DarioHealth Corp. Common Stock
DRIODarioHealth Corp. (DRIO) is a digital health company that develops and offers integrated solutions for chronic disease management, particularly focusing on diabetes care. Its platform combines hardware, software, and personalized coaching to help users monitor and improve their health outcomes. The company's approach emphasizes data-driven and user-centric tools to facilitate better disease management and support healthier lifestyles.
Company News
A study published in JMIR by Sanofi and Symphony Health revealed that DarioHealth's digital diabetes intervention platform can reduce healthcare costs by an estimated $5,077 per user annually, with 23% lower hospitalization rates and 26% lower all-cause medical charges.
DarioHealth (DRIO) delivered earnings and revenue surprises of 66.10% and 3.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
